Complement effectors generated during activation contribute to various mechanisms that limit tumor growth
Complement effectors generated during activation contribute to various mechanisms that limit tumor growth. The complement system can be activated through several distinctive pathways. The classical pathway is initiated when C1q binds to its various targets. The lectin pathway begins with the binding of mannose-binding lectin (MBL) or ficolins to pathogen associated molecular patterns (PAMPs) or apoptotic host cells. This binding activates MBL-associated serine proteases (MASPs). Finally, the alternative pathway is initiated by low-grade cleavage of C3 in plasma and the generation of small amounts of C3b. The C3b cleavage product iC3b binds to tumor cells and through the interaction with complement receptor 3 (CD11b/CD18) on mononuclear phagocytes and natural killer (NK) cells enhances antibody-dependent cellular cytotoxicity (ADCC). C5a inhibits growth of tumors in a mammary sarcoma model in mice. The terminal complement complex (TCC) is thought to contribute to complement-dependent cytotoxicity (CDC), which is one of the mechanisms for eliminating tumor cells by therapeutic antibodies. C3a, which contributes to the mobilization of hematopoietic progenitor cells, probably contributes to tumor immune surveillance. Unbroken lines connect complement proteins to functions which inhibit tumor growth, whereas broken lines connect complement proteins to functions that can currently only be hypothetically linked to inhibition of tumor growth.
Publication
Is complement good or bad for cancer patients? A new perspective on an old dilemma. () Maciej M. Markiewski, et al. Trends Immunol. ;30(6):286-292. Figure: F1.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | СзьсЗьвь | C3 | ncbigene_symbol | C3 | 718 |
| Homo sapiens | Primates | C4a | C4A | ncbigene_symbol | C4A | 720 |
| Homo sapiens | Primates | C5a | C5A | ncbigene_synonym | C5 | 727 |
| Homo sapiens | Primates | C5a | C5A | ncbigene_synonym | C5AR1 | 728 |
| Homo sapiens | Primates | MASP1 | MASP1 | ncbigene_symbol | MASP1 | 5648 |
| Homo sapiens | Primates | MASP2 | MASP2 | ncbigene_symbol | MASP2 | 10747 |
| Homo sapiens | Primates | MBL | MBL | ncbigene_synonym | MBL2 | 4153 |
| Homo sapiens | Primates | MBL | MBL | ncbigene_synonym | MBL3P | 50639 |
| Homo sapiens | Primates | C2 | C2 | ncbigene_symbol | C2 | 717 |
| Homo sapiens | Primates | C4b | C4B | ncbigene_symbol | C4B | 721 |
| Danio rerio | Vertebrates | C4 | C4 | ncbigene_symbol | c4 | 566261 |
| Danio rerio | Vertebrates | C5 | C5 | ncbigene_symbol | c5 | 565774 |
| Danio rerio | Vertebrates | MASP1 | MASP1 | ncbigene_symbol | masp1 | 100002060 |
| Danio rerio | Vertebrates | MASP2 | MASP2 | ncbigene_symbol | masp2 | 560277 |
| Danio rerio | Vertebrates | MBL | MBL | ncbigene_synonym | hbl1 | 100007982 |
| Danio rerio | Vertebrates | MBL | MBL | ncbigene_synonym | mbl2 | 100008009 |
| Danio rerio | Vertebrates | C4b | C4B | ncbigene_symbol | c4b | 794635 |
| Danio rerio | Vertebrates | lectin | LECTIN | ncbigene_symbol | lectin | 560034 |
| Word | Match | MeSH | Name | ChEBI |
|---|
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|